Santen Pharmaceutical Co., Ltd. announced the appointment of Akira Kurokawa as Representative Director of the Board and Chairman; Shigeo Taniuchi as Representative Director of the Board, President, Chief Executive Officer, Head of Human Resources Division; Takeshi Ito as Member of the Board, Executive Corporate Officer Head of Japan Business, Head of Japan Sales and Marketing Division; Kazuo Koshiji as Senior Corporate Officer, Corporate Administration, Chief Financial Officer, Head of Finance and Administration Division; Akio Kimura as Senior Corporate Officer Global Product Supply; Satoshi Suzuki as Senior Corporate Officer, Head of Corporate Development Division; Kenji Morishima as Corporate Officer, China R&D Supervisor; Takahiro Morita as Corporate Officer, Head of Marketing Department; Frank Binder as Corporate Officer, Head of Supply Chain Division; Luis Iglesias as Corporate Officer Head of EMEA Business; Ken Araki as Corporate Officer, Head of Global Business Development Department; Isao Takahashi as Corporate Officer, Head of Asia Business; Minori Hara as Corporate Officer, Chief Information Officer, Head of Information Systems Division; Peter Sallstig as Corporate Officer, Head of Product Development Division; Tatsuya Kaihara as Corporate Officer, Head of North America Business; and Takayuki Yamada as Corporate Officer Head of China Business, effective from April 1, 2020.